HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.

Abstract
Among the strategies adopted by glioma to successfully invade the brain parenchyma is turning the infiltrating microglia/macrophages (M/MΦ) into allies, by shifting them toward an anti-inflammatory, pro-tumor phenotype. Both glioma and infiltrating M/MΦ cells express the Ca(2+)-activated K(+) channel (KCa3.1), and the inhibition of KCa3.1 activity on glioma cells reduces tumor infiltration in the healthy brain parenchyma. We wondered whether KCa3.1 inhibition could prevent the acquisition of a pro-tumor phenotype by M/MΦ cells, thus contributing to reduce glioma development. With this aim, we studied microglia cultured in glioma-conditioned medium or treated with IL-4, as well as M/MΦ cells acutely isolated from glioma-bearing mice and from human glioma biopsies. Under these different conditions, M/MΦ were always polarized toward an anti-inflammatory state, and preventing KCa3.1 activation by 1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34), we observed a switch toward a pro-inflammatory, antitumor phenotype. We identified FAK and PI3K/AKT as the molecular mechanisms involved in this phenotype switch, activated in sequence after KCa3.1. Anti-inflammatory M/MΦ have higher expression levels of KCa3.1 mRNA (kcnn4) that are reduced by KCa3.1 inhibition. In line with these findings, TRAM-34 treatment, in vivo, significantly reduced the size of tumors in glioma-bearing mice. Our data indicate that KCa3.1 channels are involved in the inhibitory effects exerted by the glioma microenvironment on infiltrating M/MΦ, suggesting a possible role as therapeutic targets in glioma.
AuthorsA Grimaldi, G D'Alessandro, M T Golia, E M Grössinger, S Di Angelantonio, D Ragozzino, A Santoro, V Esposito, H Wulff, M Catalano, C Limatola
JournalCell death & disease (Cell Death Dis) Vol. 7 Pg. e2174 (Apr 07 2016) ISSN: 2041-4889 [Electronic] England
PMID27054329 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromones
  • Intermediate-Conductance Calcium-Activated Potassium Channels
  • Kcnn4 protein, mouse
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyrazoles
  • RNA, Messenger
  • TRAM 34
  • Interleukin-4
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Focal Adhesion Kinase 1
  • Ptk2 protein, mouse
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Brain (metabolism, pathology)
  • Cell Line, Tumor
  • Chromones (pharmacology)
  • Focal Adhesion Kinase 1 (genetics, metabolism)
  • Glioma (drug therapy, metabolism, pathology)
  • Humans
  • Interleukin-4 (pharmacology)
  • Intermediate-Conductance Calcium-Activated Potassium Channels (antagonists & inhibitors, genetics, metabolism)
  • Macrophages (drug effects, immunology, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia (cytology, metabolism)
  • Morpholines (pharmacology)
  • Phagocytosis (drug effects)
  • Phenotype
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors, metabolism)
  • Pyrazoles (pharmacology, therapeutic use)
  • RNA, Messenger (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: